Astaxanthin Haematococcus Pluvialis Extract Bulk Powder Manufacturer

By Hebei Finutra Biotech Co., Ltd. | Official Website — Global Leading Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel

Contact Us:

Tel: 0086-(0)311-86900072

Email: info@finutra.com

Address: Building 23B1, No.2 Yuanboyuan St., Zhengding Area of China (Hebei) Pilot Free Trade Zone

Product Information: Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel

Product Overview – Astaxanthin Haematococcus Pluvialis Extract Bulk Powder

As a top Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel, Hebei Finutra Biotech Co., Ltd. delivers world-class quality, innovation, and reliability. Astaxantina is a red carotenoid pigment derived from the microalga Haematococcus pluvialis, widely recognized for its superior antioxidant activity. This compound is in high demand across nutraceuticals, cosmetics, feed, and functional food industries due to its bioactive benefits and safety profile (NCBI).

Astaxanthin Haematococcus Pluvialis Extract Bulk Powder Manufacturer

Nombre del producto: Astaxanthin Powder
Source: Haematococcus pluvialis algae
Key Features: Non-GMO, BSE/TSE Free, Non-Irradiation, Allergen-Free
Presupuesto:
- Astaxanthin Powder: 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 5%
- Astaxanthin Oil: 5%, 10%
- Astaxanthin CWS: 1%, 2%
- Astaxanthin Beadlets: 2.5%
Product Page: Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel

Industry Trends – Astaxanthin Market Insights (2024+)

Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel segment is witnessing steady double-digit CAGR owing to rising consumer awareness, scientific endorsement (Frontiers in Nutrition), and increasing applications in anti-aging, cardiovascular, sports nutrition, and animal feed. The global astaxanthin market is projected to reach over $2.5 billion by 2027, led by dietary supplements, with Asia-Pacific and North America at the forefront of innovation.

Technological Advances: Green extraction, supercritical CO₂ extraction, advanced microencapsulation, and beadlet downstream processing.
Regulatory Trend: Emphasis on non-GMO, allergen-free, and ‘clean-label’ sourcing.
Quality Demand: Stringent standards: non-irradiation, BSE/TSE free, heavy metals/toxin residuals below global limits.
Innovation: Customizable purity grades (1%–5%+), solubility-optimized formats (oils, beadlets, cold water-soluble powders).

Technical Parameters Overview

Parameter	Description / Value	Finutra Standard
Source Species	Haematococcus pluvialis (Microalgae)	Certified Cultivation
Astaxanthin Content (Powder)	1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 5%	≥99% Purity (by HPLC)
Astaxanthin Content (Oil)	5%, 10%	Standardized
Physical Form	Powder, Oil, CWS, Beadlet	Multiple Forms/Customizable
Apariencia	Dark Red to Reddish Brown	Consistent Batch Color
Heavy Metals (Pb, As, Hg, Cd)	< 10 ppm total	Full Compliance
Microbiological Status	Aerobic Plate Count: Max 10³ cfu/g, E. coli: Negative	Safe/Monitored
GMO / Allergen Status	Non-GMO, Allergen-Free	Guaranteed
MOQ & Batch Capacity	1 kg – 20 MT/month	Flexible

Technical Specifications & Trend Analysis (Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel)

*Data visualizations based on industry analysis and Grand View Research.

Application Scenarios & End-Use Industries

Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel solutions from Finutra spans several sectors, backed by clinical and industrial validation (Nutrients Journal):

Nutraceuticals: Dietary supplements, capsules, softgels, tablets for anti-aging, eye health, immunity, and cardiovascular support.
Functional Foods & Beverages: Fortification of energy drinks, protein bars, dairy products for enhanced antioxidant profile.
Cosmeceuticals: Topical creams, serums, haircare for anti-UV, wrinkle reducing, and skin-brightening properties.
Animal Feed: Aquafeed (salmon, shrimp, trout), poultry pigmentation, and as a robust health promoter in pets and livestock feed.
Research & Pharma: Active ingredient for ocular, neuroprotective, and anti-inflammatory pharmaceutical development.
Food Coloring: As a natural colorant, it replaces synthetic pigments in food and beverages, meeting 'clean-label' consumer demand.

Expertise, Authoritativeness & Trust – Why Choose Hebei Finutra Biotech Co., Ltd.?

Decades of Specialization: Industry veteran & leading Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel with comprehensive R&D, manufacturing, and QA/QC ecosystem.
Certifications: GMP, HACCP, ISO9001:2015, Halal, Kosher, third-party tested (NutraIngredients Asia).
Technical Partnership: Collaboration with academic labs, pharmaceutical companies, and veterinary institutes (patents granted).
Traceability: Full supply chain transparency, QR batch tracking & blockchain integration for safety.
Regulatory Compliance: Products meet or exceed international standards for purity, heavy metals, microbiology, and allergens.
Customer Service: End-to-end technical support, formulation assistance, and prompt logistics.

Expert Q&A – Astaxanthin Haematococcus Pluvialis Extract Bulk Powder Manufacturer

Q1: What is the source of your astaxanthin extract?

A: All astaxanthin products are derived from Haematococcus pluvialis microalgae, cultivated in closed photobioreactors to ensure purity, environmental sustainability, and consistent quality.

Q2: Which grades and forms are available?

A: We offer astaxanthin in powders (1%–5%+), oils (5%, 10%), beadlets (2.5%), and cold water-soluble (CWS) powders (1%, 2%). Customization is available upon request.

Q3: What are your manufacturing and purity standards?

A: All products undergo HPLC purity testing and comply with global standards (non-GMO, BSE/TSE free, non-irradiation, heavy metals <10 ppm, accredited ISO/HACCP production).

Q4: Is your astaxanthin suitable for "clean label" applications?

A: Absolutely. Our extracts are allergen-free, non-irradiated, solvent-free, and produced with traceability. We provide full documentation to support clean-label claims.

Q5: How is astaxanthin bioavailability optimized?

A: Through advanced microencapsulation (beadlets, CWS), phospholipid delivery systems, and oil-dispersed forms for enhanced gastrointestinal absorption.

Q6: What is your minimum order quantity (MOQ)?

A: Flexible MOQ starts from 1kg for lab/R&D, to 1000kg+ for industrial scale, with batch capacity up to 20 metric tonnes monthly.

Q7: Which applications does your astaxanthin support?

A: Human and animal nutrition, functional foods, beverages, skincare products, pharmaceuticals, and feed. Certifications and technical sheets available per application.

Conclusion & Further Resources

As the industry demand for Fabricante de extracto de astaxantina (Haematococcus pluvialis) en polvo a granel continues its rapid rise, Hebei Finutra Biotech Co., Ltd. remains your premier, reliable, and technologically-advanced partner for premium astaxanthin ingredients. Our commitment to EEAT (Expertise, Authoritativeness, Trust) is second to none, evidenced by technical accreditations, robust safety protocols, and global client loyalty.

For bespoke support, product documentation, or to request samples, contact us at info@finutra.com or call 0086-(0)311-86900072. Discover more at the official website: https://www.finutra.com.

References: